Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study

An increased risk of lymphoma has been described in patients with inflammatory bowel disease (IBD). The aims of our study were to determine the clinical presentation, the previous exposure to immunosuppressive and biologic therapies, and the evolution of lymphomas in patients with IBD. IBD patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2023-01, Vol.15 (3), p.750
Hauptverfasser:	Guerra, Ivan, Bujanda, Luis, Mañosa, Miriam, Pérez-Martínez, Isabel, Casanova, María José, de la Peña, Luisa, de Benito, Marina, Rivero, Montserrat, Varela, Pilar, Bernal, Lorena, Franco, Ana Carolina, Ber, Yolanda, Piqueras, Marta, Tardillo, Carlos, Ponferrada, Ángel, Olivares, Sonsoles, Lucendo, Alfredo J, Gilabert, Pau, Sierra Ausín, Mónica, Bellart, María, Herrarte, Amaia, Calafat, Margalida, de Francisco, Ruth, Gisbert, Javier P, Guardiola, Jordi, Domènech, Eugeni, Bermejo, Fernando
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Biological products Chemotherapy Complications and side effects Crohn's disease Diagnosis Drug therapy Drugs Evolution Gender Hematology Immunosuppressive agents Immunotherapy Inflammatory bowel disease Inflammatory bowel diseases Intestine Leukemia Lymphoma Lymphomas Malignancy Mortality Non-Hodgkin's lymphoma Patient outcomes Patients Regression analysis Risk factors Tumor necrosis factor Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!